Jul 12, 2021 / 11:00PM GMT
Unidentified Company Representative -
Good morning. Good evening, and welcome. Thank you very much for joining Takeda Pharmaceutical's Global Finance Investor Day, a day where we would like to talk to you about how we at Takeda are creating a best-in-class finance organization by leveraging the power of data and digital. I'm [Joseph Cairnes], Senior Director of Investor Relations. I'd like to serve as the moderator today.
Before starting, I'd like to remind everyone that we will be discussing forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those discussed today. The factors that could cause our actual results to differ materially are discussed in our most recent Form 20-F and in our other SEC filings. Please also refer to the important notice on Slide 2 of the presentation today.
Now please let me hand you over to Costa Saroukos, our Chief Financial Officer, for introductory remarks.
Constantine Saroukos - Takeda Pharmaceutical Company Limited - CFO & Representative
Takeda Pharmaceutical Co Ltd Finance Investor Day Transcript
Feb 11, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers